Millipore expects its recent $1.4-billion acquisition of Serologicals to double the value of the firm by 2009, with biosciences and bioprocess remaining the two top areas of growth for the company.
The Serologicals acquisition, which was completed in July, enabled Millipore to access new high-growth research markets and placed it in more direct competition with several companies in the BCW Index, including Invitrogen, Qiagen, and Sigma-Aldrich.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.